CERN Cerner Corporation

Cerner Names New Chief Technology Officer

Cerner Names New Chief Technology Officer

Jerome Labat Brings World-Class Expertise to Health Care Technology Leader

KANSAS CITY, Mo., June 01, 2020 (GLOBE NEWSWIRE) -- (Nasdaq: CERN), a global health care technology company, announced today that Jerome Labat has joined the company as Chief Technology Officer (CTO). With more than 30 years’ experience in technology and product development leadership at other global Fortune 500 companies, including Hewlett Packard Enterprise Co. (HPE) and Oracle, Labat brings extensive experience in cloud automation, product portfolio strategy, Software-as-a-Service (SaaS) deployment and other critical engineering expertise that are well aligned with Cerner’s technology strategy.

“I’m pleased to welcome Jerome to Cerner’s executive leadership team,” said Brent Shafer, chairman and CEO, Cerner. “Jerome’s deep technology expertise, global management experience and technical depth makes him an excellent fit for Cerner. His background directly aligns with key priorities including delivering Cerner’s next-generation cognitive platform and accelerating the speed of Cerner’s technological innovations that meaningfully benefit our clients around the globe.”

As CTO, Labat will lead efforts to strengthen Cerner’s technology focus and accelerate cloud-enabled SaaS platforms and solutions. Labat has extensive experience in cloud technology and will leverage that expertise to deliver integrated cognitive functionality based on artificial intelligence and machine learning.

Prior to joining Cerner, Labat was CTO for HPE Software and led the cloud automation business. For 20 years, Labat was vice president of infrastructure automation and development operations at Oracle. Most recently, Labat served as CTO at Micro Focus International plc, a British multinational, pure play enterprise software and information technology business.

“The span of my entire career has prepared me for this role – from building software and clients’ implementations to taking products to the cloud,” said Labat. “I now have the opportunity to help shape tomorrow’s health care which is something I’m passionate about. Every Cerner associate I’ve met so far has shown they’re working to make a difference in health care and is a true advocate for the company’s mission. I look forward to combining the team’s incredible capabilities and knowledge with my experiences to meaningfully shape tomorrow’s health care.”

In addition to a successful career spanning three decades, Labat has also been issued six U.S. patents focused on software and technology advancements. , signaling a competitive edge in innovation through the next era of health care digitization. Labat’s global experience and tech savvy can help drive new technologies that improve client, clinician and consumer experiences.

Labat earned an MBA in international business administration from the Institut Supérieur de Gestion and a DEUG in economics from Université Paris X Nanterre, France.

About Cerner

Cerner’s health technologies connect people and information systems at thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit  or connect on , , or . Nasdaq: CERN. Health care is too important to stay the same.

Media Contact:

Cerner

Misti Preston, Director of External Communications & Public Relations,

 

EN
01/06/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cerner Corporation

CERNER sees an upgrade to Slightly Positive due to a better fundamenta...

The general evaluation of CERNER (US), a company active in the Software industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date December 14, 2021, the closing price was USD 77.26 and...

 PRESS RELEASE

Cerner Announces Increased Quarterly Dividend

Cerner Announces Increased Quarterly Dividend Dividend of $0.27 per issued and outstanding share reflects 23% increase KANSAS CITY, Mo., Dec. 10, 2021 (GLOBE NEWSWIRE) --  (NASDAQ: CERN), a global healthcare technology company, today announced that its board of directors declared a cash dividend to stockholders of $0.27 per issued and outstanding share, up 23 percent from the prior quarterly dividend of $0.22. The cash dividend will be payable January 11, 2022, to shareholders of record as of the close of business December 27, 2021. Cerner intends to pay regular quarterly cash dividend...

 PRESS RELEASE

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Offic...

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Officer Experienced Clinical Executive to Lead Patient and Caregiver Experiences KANSAS CITY, Mo., Nov. 16, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, today announced Nasim Afsar, MD, MBA, MHM, as the company’s first Chief Health Officer, effective January 2022. In this new role, Dr. Afsar will lead Cerner’s more than 1,000 healthcare professionals who provide insight and guidance to product development and improving the lives of patients and caregivers. She will also lead the quality...

 PRESS RELEASE

Cerner Reports Third Quarter 2021 Results

Cerner Reports Third Quarter 2021 Results Delivers Strong Results Across Key MetricsGAAP Operating Margin and Diluted EPS Lower; Adjusted Operating Margin and Adjusted Diluted EPS Both up Sharply vs. Year-Ago QuarterFull-Year Guidance Increased KANSAS CITY, Mo., Oct. 29, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: CERN) today announced results for the 2021 third quarter that ended September 30, 2021. The third quarter 2021 earnings release can be viewed as well as on the company’s website at . Cerner will host an earnings conference call to provide additional detail on the Company’s results a...

 PRESS RELEASE

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcome...

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcomes Combining decades of healthcare, life sciences and collaborative research to transform the way care is delivered KANSAS CITY, Mo., Oct. 26, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, announces the launch of a new operating unit, SM, that offers data-driven solutions and research services to help bring clarity to multi-dimensional data through real-world evidence and insights. The combined expertise of the Cerner and Kantar Health teams is expected to help accelerate discovery, ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch